The Filing Desk

Alto Ingredients vs Aspen Aerogels

Alto Ingredients ALTO · Aspen Aerogels ASPN · Specialty Chemicals

Alto Ingredients reported revenue of $918 million in fiscal 2025, 3.4 times Aspen Aerogels' $271 million in fiscal 2025. Alto Ingredients' revenue fell 4.9% in its latest year, and Aspen Aerogels' fell 40.1%. Alto Ingredients had an operating margin of 0.8%, against -139.5% at Aspen Aerogels. Free cash flow was $9 million at Alto Ingredients and −$5 million at Aspen Aerogels.

Side by side

Alto IngredientsAspen Aerogels
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$918M$271M
Revenue growth−4.9%−40.1%
Revenue growth a year, last 5 years0.5%22.0%
Gross margin3.8%17.0%
Operating margin0.8%−139.5%
Net margin1.4%−143.7%
Free cash flow$9M−$5M
Free cash flow margin0.9%−1.7%
Return on capital2.5%−93.7%
Net debt to EBITDA1.9x—
Dividends and buybacks$0M$0M
Change in diluted share count3.0%2.5%
Last close$3.66$5.58
P/E at the last close5.6×—
Insider trades, last 12 monthsbought $361,250, sold $0sold $58.1 million
Piotroski F-score6 of 94 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Alto IngredientsAspen Aerogels
Operating margin
Percent of revenue
Alto IngredientsAspen Aerogels
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Alto IngredientsAspen Aerogels

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Alto Ingredients and Aspen Aerogels pages.